Display options
Cite
Park S, Bang JI, Lee HY, et al. Does (131)I Radioactivity Interfere with Thyroglobulin Measurement in Patients Undergoing Radioactive Iodine Therapy with Recombinant Human TSH?. Nucl Med Mol Imaging. 2015;49(2):122-6doi: 10.1007/s13139-014-0317-x.
Park, S., Bang, J. I., Lee, H. Y., & Kim, S. E. (2015). Does (131)I Radioactivity Interfere with Thyroglobulin Measurement in Patients Undergoing Radioactive Iodine Therapy with Recombinant Human TSH?. Nuclear medicine and molecular imaging, 49(2), 122-6. https://doi.org/10.1007/s13139-014-0317-x
Park, Sohyun, et al. "Does (131)I Radioactivity Interfere with Thyroglobulin Measurement in Patients Undergoing Radioactive Iodine Therapy with Recombinant Human TSH?." Nuclear medicine and molecular imaging vol. 49,2 (2015): 122-6. doi: https://doi.org/10.1007/s13139-014-0317-x
Park S, Bang JI, Lee HY, Kim SE. Does (131)I Radioactivity Interfere with Thyroglobulin Measurement in Patients Undergoing Radioactive Iodine Therapy with Recombinant Human TSH?. Nucl Med Mol Imaging. 2015 Jun;49(2):122-6. doi: 10.1007/s13139-014-0317-x. Epub 2015 Jan 27. PMID: 26085857; PMCID: PMC4463868.
Copy Download .nbib Format: NLM
Share it on

Nucl Med Mol Imaging. 2015 Jun;49(2):122-6. doi: 10.1007/s13139-014-0317-x. Epub 2015 Jan 27.

Does (131)I Radioactivity Interfere with Thyroglobulin Measurement in Patients Undergoing Radioactive Iodine Therapy with Recombinant Human TSH?.

Nuclear medicine and molecular imaging

Sohyun Park, Ji-In Bang, Ho-Young Lee, Sang-Eun Kim

Affiliations

  1. Department of Nuclear Medicine, Seoul National University Bundang Hospital, 173-82, Gumi-ro, Bundang-gu, Seongnam-si, Gyeonggi-do 463-707 Republic of Korea ; Department of Nuclear Medicine, Seoul National University College of Medicine, Seoul, Korea.
  2. Department of Nuclear Medicine, Seoul National University Bundang Hospital, 173-82, Gumi-ro, Bundang-gu, Seongnam-si, Gyeonggi-do 463-707 Republic of Korea ; Department of Nuclear Medicine, Seoul National University College of Medicine, Seoul, Korea ; Laboratory of Molecular Imaging and Therapy of Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea.

PMID: 26085857 PMCID: PMC4463868 DOI: 10.1007/s13139-014-0317-x

Abstract

OBJECTIVES: Recombinant human thyroid-stimulating hormone (rhTSH) is widely used in radioactive iodine therapy (RIT) to avoid side effects caused by hypothyroidism during the therapy. Owing to RIT with rhTSH, serum thyroglobulin (Tg) is measured with high (131)I concentrations. It is of concern that the relatively high energy of (131)I could interfere with Tg measurement using the immunoradiometric assay (IRMA). We investigated the effect of (131)I administration on Tg measurement with IRMA after RIT.

METHODS: A total of 67 patients with thyroid cancer were analysed retrospectively. All patients had undergone rhTSH stimulation for RIT. The patients' sera were sampled 2 days after (131)I administration and divided into two portions: for Tg measurements on days 2 and 32 after (131)I administration. The count per minute (CPM) of whole serum (200 μl) was also measured at each time point. Student's paired t-test and Pearson's correlation analyses were performed for statistical analysis.

RESULTS: Serum Tg levels were significantly concordant between days 2 and 32, irrespective of the serum CPM. Subgroup analysis was performed by classification based on the (131)I dose. No difference was noted between the results of the two groups.

CONCLUSIONS: IRMA using (125)I did not show interference from (131)I in the serum of patients stimulated by rhTSH.

Keywords: Immunoradiometric assay; Radioactive iodine therapy; Recombinant human TSH; Thyroglobulin

References

  1. Cancer. 2003 Jul 1;98(1):41-7 - PubMed
  2. Ann Clin Biochem. 2013 Sep;50(Pt 5):421-32 - PubMed
  3. J Clin Endocrinol Metab. 2013 Jul;98(7):2693-700 - PubMed
  4. Ann Clin Biochem. 2011 Jul;48(Pt 4):367-9 - PubMed
  5. Thyroid. 2012 Nov;22(11):1165-9 - PubMed
  6. Eur J Endocrinol. 2014 Aug;171(2):247-52 - PubMed
  7. Nucl Med Mol Imaging. 2014 Dec;48(4):255-61 - PubMed
  8. Thyroid. 2009 Nov;19(11):1167-214 - PubMed
  9. Clin Endocrinol (Oxf). 2007 Sep;67(3):434-41 - PubMed
  10. J Clin Endocrinol Metab. 2010 Apr;95(4):1672-80 - PubMed
  11. Eur J Nucl Med. 1991;18(3):153-7 - PubMed
  12. Clin Endocrinol (Oxf). 2011 Jan;74(1):111-7 - PubMed
  13. Thyroid. 2014 Oct;24(10):1501-7 - PubMed
  14. Clin Chem Lab Med. 2002 May;40(5):480-4 - PubMed
  15. Q J Nucl Med Mol Imaging. 2004 Sep;48(3):237-42 - PubMed
  16. J Endocrinol Invest. 2012 May;35(5):459-63 - PubMed
  17. Thyroid. 2014 Mar;24(3):480-7 - PubMed
  18. J Clin Lab Anal. 2007;21(3):147-53 - PubMed
  19. Endocr Pract. 2013 Jan-Feb;19(1):157-61 - PubMed
  20. J Nucl Med. 2001 Oct;42(10 ):1470-5 - PubMed
  21. J Clin Endocrinol Metab. 2003 Apr;88(4):1433-41 - PubMed
  22. J Korean Med Sci. 2014 Jun;29(6):811-7 - PubMed
  23. Radiology. 2014 Oct;273(1):211-9 - PubMed
  24. Nucl Med Commun. 2014 Jul;35(7):727-32 - PubMed
  25. Eur J Nucl Med Mol Imaging. 2014 Sep;41(9):1767-80 - PubMed
  26. Nat Rev Endocrinol. 2010 Apr;6(4):185-6 - PubMed

Publication Types